55513-078Level 3
Imlygic (talimogene laherparepvec)
**Product type:** Human Prescription Drug
**Active ingredient:** TALIMOGENE LAHERPAREPVEC
**Strength:** 1000000 [PFU]/mL
**Dosage form:** Injection, Suspension
**Route:** Intralesional
**Labeler:** Amgen Inc
**Marketing category:** BLA (BLA125518)
GET
/api/v1/systems/ndc_fda/nodes/55513-078Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.